NTLA - Intellia Therapeutics, Inc.
13.44
0.290 2.158%
Share volume: 3,311,227
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$13.15
0.29
0.02%
Summary score
40%
Profitability
25%
Dept financing
30%
Liquidity
50%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.37%
Return on assets
-4.65%
Return on sales
0%
Return on invested capital
161.33%
Total debt ratio
28.9%
Debt ratio change over timeo
0%
Current Ratio
10.16%
Quick Ratio
0%
Cash Position Ratio
9.25%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.1%
Return on assets
-5.17%
Return on sales
0%
Return on invested capital
188.18%
Total debt ratio
29.22%
Debt ratio change over timeo
0%
Current Ratio
9.46%
Quick Ratio
0%
Cash Position Ratio
9.25%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-8.73%
Return on assets
-6.37%
Return on sales
0%
Return on invested capital
270.88%
Total debt ratio
29.43%
Debt ratio change over time
0%
Current Ratio
8.88%
Quick Ratio
0%
Cash Position Ratio
8.62%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NTLA | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -6.37% | -176.74% | -7.74% | -0.57% |
| Return on assets | -4.65% | 6.25% | 5.11% | 1.02% |
| Return on sales | 0% | 20.77% | 16.76% | 4.64% |
| Return on invested capital | 161.33% | -40.52% | 7.04% | -0.66% |
| Profitability | 25% | 50% | 42% | 35% |
| Total debt ratio | 28.9% | 102.82% | 137.99% | 47.62% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 19% | 25% | 9% |
| Current Ratio | 9.46% | 0.91% | 2.78% | 7.15% |
| Quick Ratio | 0% | 0.73% | 2.31% | 6.43% |
| Cash Position Ratio | 9.25% | 0.17% | 1.25% | 5.46% |
| Liquididy | 50% | 6% | 19% | 58% |
| Short-term ratios | NTLA | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -7.1% | -96.34% | -8.8% | -0.64% |
| Return on assets | -5.17% | 6.16% | 5.2% | 1.12% |
| Return on sales | 0% | 20.68% | 16.83% | 4.63% |
| Return on invested capital | 188.18% | -28.64% | 7.79% | -0.73% |
| Profitability | 25% | 50% | 42% | 35% |
| Total debt ratio | 29.22% | 104.99% | 135.61% | 47.59% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 19% | 25% | 9% |
| Current Ratio | 9.46% | 0.91% | 2.78% | 7.15% |
| Quick Ratio | 0% | 0.73% | 2.31% | 6.43% |
| Cash Position Ratio | 9.25% | 0.17% | 1.25% | 5.46% |
| Liquididy | 50% | 6% | 20% | 59% |